0K4O Stock Chart & Stats
€19.39
€0.10(0.52%)
At close: 4:00 PM EDT
€19.39
€0.10(0.52%)
Day’s Range― - ―
52-Week Range€18.08 - €23.00
Previous CloseN/A
Volume21.00
Average Volume (3M)14.98K
Market Cap
€1.46B
Enterprise Value€4.68K
Total Cash (Recent Filing)€780.90M
Total Debt (Recent Filing)€4.00B
Price to Earnings (P/E)―
Beta1.01
Next Earnings
Feb 22, 2027EPS Estimate
1.2Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.47
Shares Outstanding76,234,540
10 Day Avg. Volume33,315
30 Day Avg. Volume14,983
Financial Highlights & Ratios
PEG Ratio0.24
Price to Book (P/B)0.43
Price to Sales (P/S)1.15
P/FCF Ratio-327.09
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€22.60Price Target Upside16.55% Upside
Rating ConsensusHold
Number of Analyst Covering4
EPS Forecast (FY)2.88
Revenue Forecast (FY)€299.43M
Bulls Say, Bears Say
Bulls Say
Healthcare-focused Integrated ModelIcade’s integrated investor-developer model concentrated on healthcare real estate creates durable structural demand: long-term leases and specialized healthcare assets support recurring rental income while development activity provides fee and capital gain potential, diversifying cashflow sources over time.
Consistent Operating Cash FlowOperating cash flow has remained positive each year, reflecting steady rental receipts from the investment portfolio. This persistent OCF provides a durable cash buffer to service debt and fund operations even as earnings fluctuate, supporting longer-term financial resilience and execution of projects.
Improving Leverage / Serviceable Balance SheetReported leverage is meaningful but improved from 2022, with debt roughly 1.0–1.2x equity, implying a serviceable balance sheet for a diversified REIT. Improved leverage increases financial flexibility for development and asset management while lowering refinancing strain relative to prior peak levels.
Bears Say
Persistent Net LossesConsecutive net losses in 2023–2025 and negative margins indicate structural profitability weakness. Persistent losses erode equity, depress ROE, and limit retained earnings, constraining the company’s ability to self-fund development, sustain payouts, or invest without external financing over the medium term.
Weak Revenue TrendsTop-line trends have been weak: revenue has been broadly flat to down with an overall decline (-9.09% shown). Stagnant or falling revenues reduce scale benefits, tighten development margin prospects, and make margin and cashflow recovery more difficult without a sustained improvement in leasing or development volumes.
Inconsistent Free Cash FlowFree cash flow has been inconsistent—positive in some years but negative in 2021, 2022 and slightly negative in 2025—limiting the firm’s ability to fund growth, complete development programs, and comfortably cover dividends without tapping capital markets or increasing leverage.
Icade SA News
0K4O FAQ
What was Icade SA’s price range in the past 12 months?
Icade SA lowest share price was €18.08 and its highest was €23.00 in the past 12 months.
What is Icade SA’s market cap?
Icade SA’s market cap is €1.46B.
When is Icade SA’s upcoming earnings report date?
Icade SA’s upcoming earnings report date is Feb 22, 2027 which is in 190 days.
How were Icade SA’s earnings last quarter?
Icade SA released its earnings results on Jul 21, 2026. The company reported €1.17 earnings per share for the quarter, missing the consensus estimate of €1.24 by -€0.07.
Is Icade SA overvalued?
According to Wall Street analysts Icade SA’s price is currently Undervalued.
Does Icade SA pay dividends?
Icade SA does not currently pay dividends.
What is Icade SA’s EPS estimate?
Icade SA’s EPS estimate is 1.2.
How many shares outstanding does Icade SA have?
Icade SA has 76,234,540 shares outstanding.
What happened to Icade SA’s price movement after its last earnings report?
Icade SA reported an EPS of €1.17 in its last earnings report, missing expectations of €1.24. Following the earnings report the stock price went down -0.418%.
Which hedge fund is a major shareholder of Icade SA?
Currently, no hedge funds are holding shares in GB:0K4O
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Icade SA
Icade functions as a comprehensive real estate entity, actively investing in and developing properties. It specializes in crafting innovative real estate solutions and offerings tailored to evolving urban lifestyles and demands. With corporate social responsibility and innovation central to its strategic approach, Icade cultivates close relationships with a broad spectrum of urban stakeholders, including local governments, communities, businesses, their employees, and various institutions and associations. The company is a significant investor in office and healthcare properties, possessing a portfolio valued at €11.6 billion (as of June 30, 2020, on a proportionate consolidation basis), and also operates as a robust property developer, generating nearly €1 billion in economic revenues in 2019. Through these endeavors, Icade has redefined the real estate sector, championing the emergence of tomorrow's greener, smarter, and more responsible urban environments. Its operations are particularly prominent across the Greater Paris region and other major French cities. Icade is publicly traded on Euronext Paris as a French Listed Real Estate Investment Company (société d'investissement immobilier cotée, SIIC), and its primary shareholder is the Caisse des dépôts Group.
0K4O Stock 12 Month Forecast
Average Price Target
€22.60
▲(16.55% Upside)